# Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

> **NCT05298761** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sheikh Zayed Medical College** · enrollment: 60 (estimated)

## Conditions studied

- Hemodynamic Stability

## Interventions

- **DRUG:** Lignocaine

## Key facts

- **NCT ID:** NCT05298761
- **Lead sponsor:** Sheikh Zayed Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-30
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298761, "Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05298761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*